Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Overall survival
Timeframe: 1 year
Time to laboratory value normalization
Timeframe: From Index date up to 26 weeks
Time to Macrophage Activation Syndrome (MAS) laboratory remission
Timeframe: From Index date up to 26 weeks
Time to partial MAS laboratory remission
Timeframe: From Index date up to 26 weeks
Time to tapering of Glucocorticoids (GCs)
Timeframe: from index date to the last of 7 consecutive days
Number of recurrent MAS episodes
Timeframe: through study completion
Administration of organ support care
Timeframe: from the index date until either the end of hospitalization or 26 weeks, whichever occurs later
Characteristics of MAS treatment
Timeframe: for MAS episodes occurring during the data collection period
Clinical signs
Timeframe: At index date and 8 weeks after index date or at the earliest time this data becomes available between 8 and 12 weeks